Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(S1):S3–14. https://doi.org/10.1002/2327-6924.12510.
Article PubMed PubMed Central Google Scholar
Melián-Fleitas L, Franco-Pérez Á, Sanz-Valero J, Wanden-Berghe C. Population Interest in Information on Obesity, Nutrition, and Occupational Health and Its Relationship with the Prevalence of Obesity: An Infodemiological Study. Nutrients. 2023;15(17):3773. https://doi.org/10.3390/nu15173773.
Article PubMed PubMed Central Google Scholar
Kelly T, Yang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008;32(9):1431–7. https://doi.org/10.1038/ijo.2008.102.
Article CAS PubMed Google Scholar
Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism. 2022;133:155217. https://doi.org/10.1016/j.metabol.2022.155217.
Article CAS PubMed PubMed Central Google Scholar
Kovesdy CP. 2022 Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2011;12(1):7–11. https://doi.org/10.1016/j.kisu.2021.11.003.
Mills KT, Xu Y, Zhang W, Bundy JD, Chen CS, Kelly TN, Chen J, He J. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–7. https://doi.org/10.1038/ki.2015.230.
Article PubMed PubMed Central Google Scholar
Wilson S, Mone P, Jankauskas SS, Gambardella J, Santulli G. Chronic kidney disease: Definition, updated epidemiology, staging, and mechanisms of increased cardiovascular risk. J Clin Hypertens (Greenwich). 2021;23(4):831–4. https://doi.org/10.1111/jch.14186.
Article CAS PubMed Google Scholar
Kreiner FF, Schytz PA, Heerspink HJL, von Scholten BJ, Idorn T. Obesity-Related Kidney Disease: Current Understanding and Future Perspectives. Biomedicines. 2023;11(9):2498. https://doi.org/10.3390/biomedicines11092498.
Article CAS PubMed PubMed Central Google Scholar
Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–90. https://doi.org/10.1016/S0140-6736(18)31694-5.
Article PubMed PubMed Central Google Scholar
Brück K, Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ, European CKD Burden Consortium. CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2016;27(7):2135–47. https://doi.org/10.1681/ASN.2015050542.
Yarnoff BO, Hoerger TJ, Shrestha SS, Simpson SK, Burrows NR, Anderson AH, Xie D, Chen HY, Pavkov ME, CRIC Study Investigators. Modeling the impact of obesity on the lifetime risk of chronic kidney disease in the United States using updated estimates of GFR progression from the CRIC study. PLoS One. 2018;13(10):e0205530. https://doi.org/10.1371/journal.pone.0205530.
Article CAS PubMed PubMed Central Google Scholar
Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ. Association between obesity and kidney disease: a systematic review and meta-analysis. Kidney Int. 2008;73(1):19–33. https://doi.org/10.1038/sj.ki.5002586.
Article CAS PubMed Google Scholar
Sawyer A, Zeitler E, Trachtman H, Bjornstad P. Kidney Considerations in Pediatric Obesity. Curr Obes Rep. 2023;12(3):332–44. https://doi.org/10.1007/s13679-023-00522-3.
Nawaz S, Chinnadurai R, Al-Chalabi S, Evans P, Kalra PA, Syed AA, Sinha S. Obesity and chronic kidney disease: A current review. Obes Sci Pract. 2022;9(2):61–74. https://doi.org/10.1002/osp4.629.
Article PubMed PubMed Central Google Scholar
Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am. 2013;97(1):59–74. https://doi.org/10.1016/j.mcna.2012.10.010.
Hoogeveen EK. The Epidemiology of Diabetic Kidney Disease. Kidney Dial. 2022;2(3):433–42. https://doi.org/10.3390/kidneydial2030038.
Grillo MA, Mariani G, Ferraris JR. Prematurity and Low Birth Weight in Neonates as a Risk Factor for Obesity, Hypertension, and Chronic Kidney Disease in Pediatric and Adult Age. Front Med (Lausanne). 2022;8:769734. https://doi.org/10.3389/fmed.2021.769734.
Luyckx VA, Brenner BM. Birth weight, malnutrition and kidney-associated outcomes–a global concern. Nat Rev Nephrol. 2015;11(3):135–49. https://doi.org/10.1038/nrneph.2014.251.
Zhu P, Herrington WG, Haynes R, Emberson J, Landray MJ, Sudlow CLM, Woodward M, Baigent C, Lewington S, Staplin N. Conventional and Genetic Evidence on the Association between Adiposity and CKD. J Am Soc Nephrol. 2021;32(1):127–37. https://doi.org/10.1681/ASN.2020050679.
Article CAS PubMed Google Scholar
Look AHEAD Research Group. Effect of a long-term behavioral weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomized clinical trial. Lancet Diabetes Endocrinol. 2014;2(10):801–9. https://doi.org/10.1016/S2213-8587(14)70156-1.
Kramer H, Gutiérrez OM, Judd SE, Muntner P, Warnock DG, Tanner RM, Panwar B, Shoham DA, McClellan W. Waist Circumference, Body Mass Index, and ESRD in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study. Am J Kidney Dis. 2016;67(1):62–9. https://doi.org/10.1053/j.ajkd.2015.05.023.
Kovesdy CP, Furth SL, Zoccali C, World Kidney Day Steering Committee. Obesity and Kidney Disease: Hidden Consequences of the Epidemic. Can J Kidney Health Dis. 2017;4:2054358117698669. https://doi.org/10.1177/2054358117698669.
Article PubMed PubMed Central Google Scholar
Subramanian SV, Perkins JM, Ozaltin E, Davey SG. Weight of nations: a socioeconomic analysis of women in low- to middle-income countries. Am J Clin Nutr. 2011;93:413–21. https://doi.org/10.3945/ajcn.110.004820.
Article CAS PubMed Google Scholar
Cavaliere G, Cimmino F, Trinchese G, Catapano A, Petrella L, D’Angelo M, Lucchin L, Mollica MP. From Obesity-Induced Low-Grade Inflammation to Lipotoxicity and Mitochondrial Dysfunction: Altered Multi-Crosstalk between Adipose Tissue and Metabolically Active Organs. Antioxidants (Basel). 2023;12(6):1172. https://doi.org/10.3390/antiox12061172.
Article CAS PubMed Google Scholar
White U. Adipose tissue expansion in obesity, health, and disease. Front Cell Dev Biol. 2023;11:1188844. https://doi.org/10.3389/fcell.2023.1188844.
Article PubMed PubMed Central Google Scholar
Ali MM, Parveen S, Williams V, Dons R, Uwaifo GI. Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD). J Clin Transl Endocrinol. 2024;36:100341. https://doi.org/10.1016/j.jcte.2024.100341.
Article CAS PubMed PubMed Central Google Scholar
Castro BBA, Foresto-Neto O, Saraiva-Camara NO, Sanders-Pinheiro H. Renal lipotoxicity: Insights from experimental models. Clin Exp Pharmacol Physiol. 2021;48(12):1579–88. https://doi.org/10.1111/1440-1681.13556.
Article CAS PubMed Google Scholar
Ryu JH, Ge M, Merscher S, Rosenberg AZ, Desante M, Roshanravan H, Okamoto K, Shin MK, Hoek M, Fornoni A, Kopp JB. APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice. PLoS ONE. 2019;14(4):e0211559. https://doi.org/10.1371/journal.pone.0211559.
Comments (0)